Mexico has seen the launch of FemTech.Mx, the first association of its kind in Latin America [1].
The organization represents a strategic shift toward integrating technology into women's healthcare. By supporting innovative projects, the group seeks to address historical gaps in medical research and treatment specifically tailored to female biology.
Mayra Hurtado, the CEO and co-founder of Hormony, leads the association alongside Jazna Stannard [1]. The group officially debuted at the end of October during Mexico Tech Week [2].
The primary objective of FemTech.Mx is to promote female health by supporting technology projects that foster a more equitable and inclusive health system [1]. The organization focuses on creating an evidence-based approach to wellbeing, ensuring that technological advancements are grounded in scientific data [2].
This initiative arrives as part of a broader movement to utilize "FemTech" — technology designed to improve women's health — to solve systemic issues in healthcare delivery. The association intends to provide a framework for innovation that empowers both developers and patients within the region [1].
By centralizing resources and leadership, FemTech.Mx aims to accelerate the development of tools that monitor and treat conditions that disproportionately affect women. This collaborative effort is designed to bridge the gap between scientific innovation and clinical application in Mexico and across Latin America [2].
“FemTech.Mx is the first FemTech association in Latin America”
The establishment of FemTech.Mx signals a formalization of the female health technology sector in Latin America. By moving from individual startups to a coordinated association, the region can better challenge the 'gender data gap' in medicine, potentially leading to more accurate diagnostics and personalized treatments for women.
